Skip to main content

General Psychiatry

Scientists from 3 diverse disciplines at Purdue University, West Lafayette, Indiana, have developed a new material that can sense the neurotransmitter glutamate in the brain.
SPONSORED CONTENT
As part of its commitment to nurse practitioners (NPs) who are treating patients with mental illness, AbbVie today announced the launch of NP Psych Navigator, a centralized resource that connects NPs with tools to help them identify mental illness…
BLOG: In a recent study, the utilization of psychedelic medicine in group therapy was linked with reduced demoralization among long-term, gay-identified, male HIV survivors—an outcome with larger implications for overall healthcare.
Two studies released this month have brought into focus the degree to which Americans are turning to illicit substances and alcohol in response to the stress brought on by the COVID-19 pandemic.
Although the situation has improved, a quarter of general hospital admissions involving people with severe mental illness in 2017 failed to record a psychiatric condition, according to a study published online in PLOS Medicine.
Psych Congress 2020 speaker Marc E. Agronin, MD, shares strategies that mental health clinicians can use to adjust psychopharmacologic treatment and dosages for geriatric patients.
At Psych Congress Elevate, Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discussed clinician burnout and using wellness practices as a possible antidote. In this podcast, she…
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, speaks with general psychiatrist Abbey Strauss, MD, MSW, about the history, chemistry, and potential use of the neurotransmitter…
In this podcast, Michael F. Myers, MD interviews fellow psychiatrists John Budin, MD, and John S. Tamerin, MD, about mental health professionals living with psychiatric illness and how their needs…
Back to Top